Clinical trial
A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of NV-101 in Dental Patients
NCT00154167 is registered in ClinicalTrials.gov with Novalar Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of NV-101 in Dental Patients
- Lead sponsor
- Novalar Pharmaceuticals, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2003
- Completion date
- June 30, 2003
- Enrollment
- 122
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
soft tissue anesthesia (numbness)